BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2556337)

  • 1. [Analysis of 293 cases of hepatocellular carcinoma of recent ten years--II. Diagnosis, therapy and prognosis].
    Miyanaga O; Miyamoto Y; Jyo R; Nakao T; Koga T; Saito S; Koyanagi K; Yamaguchi S; Endo M; Shirahama M
    Fukuoka Igaku Zasshi; 1989 Nov; 80(11):495-502. PubMed ID: 2556337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, treatment and prognosis of small hepatocellular carcinoma.
    Watanabe A; Yamamoto H; Ito T; Nagashima H
    Hepatogastroenterology; 1986 Apr; 33(2):52-5. PubMed ID: 3013739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma.
    Yoshioka H; Sato M; Sonomura T; Terada M; Kishi K; Yoshikawa A
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-29-S6-37. PubMed ID: 9151914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
    Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases.
    Kenji J; Hyodo I; Tanimizu M; Tanada M; Nishikawa Y; Hosokawa Y; Mandai K; Moriwaki S
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-71-S6-80. PubMed ID: 9151920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
    Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
    Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma with extrahepatic malignancies].
    Yoshikawa K; Mikata S; Inoue M; Amemiya A; Iwasaki T; Moriguchi S; Emoto T; Han N; Itou A
    Gan No Rinsho; 1990 Jan; 36(1):23-8. PubMed ID: 1688958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
    Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of 293 cases of hepatocellular carcinoma of recent ten years--I. Epidemiology, anamnesis and tumor occupying rate].
    Miyanaga O; Nakao T; Jyo R; Koga T; Shirahama M; Saito S; Yamaguchi S; Koyanagi K; Endo M; Miyamoto Y
    Fukuoka Igaku Zasshi; 1989 Nov; 80(11):486-94. PubMed ID: 2556336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of hepatocellular carcinoma by chemoembolization].
    Marchiori L; Mansueto GC; Nifosi F; Bortolasi L; Dal Dosso I; Facci E; Perus G; Nicoli N
    Chir Ital; 1994; 46(1):17-22. PubMed ID: 8025966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.
    Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hepatocellular carcinoma by alcohol injection into the tumor and irradiation of the tumor].
    Ohto M; Sugiura N; Ebara M; Kimura K; Isomura S; Watanabe Y
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1625-34. PubMed ID: 3015037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.